Our experience

Our portfolio companies and potential investments operate in the healthcare sector, primarily based in the Nordic region. The companies we invest in shall contribute to an improved quality of care, increased availability of care, reduced or postponed need for care, more care for an existing budget and/or preventive care. We find common ground in our long-term efforts to give people the opportunity to enjoy healthier lives in the future. 

Portfolio and experiences

Impilo creates value in its investee companies through active involvement and long-term perspective, which enable us to set positive and challenging objectives, diligently follow up on execution, provide new resources while showing an understanding and respect for the investee companies’ cultures – all in order to promote their development. Below you can read more about our investments and how our view of transparent companionship leads to robust business in the long term.

image001 (2)


LOWENCO develops, manufactures, markets, and installs large scale modular and highly energy efficient ultra-low temperature (“ULT”) storage solutions for commercial biopharma primarily targeting the drug substance market.
image001 (1)


tandlægen.dk is the leading Danish dental care chain. Founded in 2016, today it comprises 52 clinics across all regions in Denmark, employs over 800 professionals and serves more than a quarter of a million patients per year.
Microscope is used for conducting planned, research experiments, educational demonstrations in medical and health institutions, lab.


Founded in 1977, Scantox is a market leading GLP (“Good Laboratory Practice”) accredited contract research organisation (”CRO”) located outside of Copenhagen.

Mallax Pharmaceuticals

Mallax Pharmaceuticals was established in Q4 2020 by Impilo together with Anders Larnholt, an experienced pharma executive, as a pharma company ‘ready-to-use’ with required pharmaceutical processes and licenses

Euro Accident

Euro Accident is a leading Swedish specialist in health-related insurance and employee wellbeing, active primarily within the long-term disability (LTD), private health insurance (PHI), group life and accident markets.

The Fertility Partnership

The Fertility Partnership, with the acquisition of VivaNeo, is the leading Northern European provider of fertility treatments, with c. 24,000 cycles annually, incl. adjacent services.


Humana is a Nordic care company with a focus on quality and customer satisfaction. The company is a market leader in individual and family care and personal assistance, with expanding operations in elderly care. Humana has 15,000 employees who all work with a shared vision – Everyone is entitled to a good life.

Immedica Pharma

Immedica is engaged in commercialization and distribution of orphan and niche specialty pharmaceuticals across Europe and the Middle East.

Ferrosan Medical Devices

FMD is the world’s largest manufacturer of gelatine-based bioabsorbable hemostatic products for use in surgical procedures, and also has a smaller electromechanical contract manufacturing activity, based in Søborg, Denmark.


NutraQ is a leading supplier of subscription-based health and wellness products in the Nordic region. The company was established in Norway in 2002 and at Impilo’s entry in 2017, the company had a strong presence in Norway, Sweden, Finland, Czech Republic and an emerging presence in Denmark.


Cavidi is a diagnostic company developing assays and an automated instrument for HIV viral load monitoring. The Ziva™ system, targeting district hospitals and regional laboratories (the mid-marketsegment) in the African market, is built on the company’s longstanding chemistry solution used in its manual testing product.

Redefining partnership

We strongly believe that true progress comes from strong partnerships. The Impilo team strives to be a talented partner with an ambitious, long-term and open approach, seeking to be the wind under the wings of others.